Ai Feedback
Exact(4)
Mean follow-up was 18 months and range 12 months to 4 years.
Median time to progression was 6 months and median duration of treatment was 5 months (range, 0,7 to 18.4 months and range, 1 to 18 months, respectively).
The mean age (SD) of children was 7.6 (4.8) months, median age 7 months and range of 2 to 28 months.
The mean treatment time for the PD patients attending follow-up was 16.6 months (SD 5.9), median 18 months, and range 4 to 24 months, and the mean follow-up time since treatment termination was 9.8 months (SD 6.4), median 10.4 months, and range 0 to 26 months.
Similar(56)
Follow-up averaged 33 months and ranged from 24 to 58 months.
The median follow-up time was 11.4 months and ranged from 1.1 months to 58.5 months.
The median follow-up time for the breast cancer patients was 60 months and ranged from 8to6464 months.
Time in study is coded in months and ranges from 0.49 to 18 months, with a mean of 8.60 months.
The mean (± SD) age at end of follow-up was 48±± 7 months and ranged from 36 to 59 months.
The median survival duration for all patients was 17 months and ranged from 4 to 81 months.
The mean ± SD duration of imatinib treatment was 26.1 ± 19.9 months, and ranged from 1 to 69.8 months.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com